Form 8-K Adaptive Biotechnologies For: Apr 01
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/17/2026
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Netflix earnings forecast disappoints Wall Street, shares tumble
- Alphabet stock falls on report of Gemini AI model delays
- TSMC Q2 profit jumps 77% to record, far surpasses expectations
- Oil settles lower, but remains near one-month high on U.S.-Iran tension
- FDA approves Merck's Lipfendra as first oral PCSK9 inhibitor
- Intuitive Surgical (ISRG) Tops Q2 EPS by 29c, Beats on Revenue
- Wall Street ends lower as chip weakness offsets solid earnings, economic data
- Personalis (PSNL) explores potential sale after interest from Merck and others - source
- Boeing nears approval of 737 MAX anti-ice fix, paving way for deliveries
Adaptive Biotechnologies (ADPT) Announces CFO Resignation
April 2, 2024 4:14 PM EDTOn April 1, 2024, the Chief Financial Officer of Adaptive Biotechnologies (NASDAQ: ADPT) Tycho Peterson submitted his resignation. The resignation was voluntary and not due to any disagreement with the Company on any matter relating to its operations, policies or practices. Mr. Petersons planned departure... More
